KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Gains from Sales and Divestitures (2023 - 2025)

Globus Medical filings provide 3 years of Gains from Sales and Divestitures readings, the most recent being $117000.0 for Q3 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 66.86% to $117000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $117000.0, a 66.86% decrease, with the full-year FY2024 number at $18000.0, up 800.0% from a year prior.
  • Gains from Sales and Divestitures hit $117000.0 in Q3 2025 for Globus Medical, up from $20000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $432000.0 in Q3 2023 to a low of $2000.0 in Q4 2023.
  • Median Gains from Sales and Divestitures over the past 3 years was $20000.0 (2025), compared with a mean of $139222.2.
  • Biggest five-year swings in Gains from Sales and Divestitures: skyrocketed 800.0% in 2024 and later plummeted 93.42% in 2025.
  • Globus Medical's Gains from Sales and Divestitures stood at $2000.0 in 2023, then skyrocketed by 800.0% to $18000.0 in 2024, then skyrocketed by 550.0% to $117000.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $117000.0 (Q3 2025), $20000.0 (Q2 2025), and $2000.0 (Q1 2025) per Business Quant data.